New Study Shows CBD Can Ease Public Speaking Anxiety

January 21, 2020 16:00:17

Unless you’ve been living under a rock for the past few years, you have undoubtedly heard about cannabidiol (CBD), or maybe even tried it. The hemp extract has been having a fantastic run, with new testimonials on its benefits coming to light almost every day, accompanied by a government that seems interested in furthering research into the compound.

The chemical is said to be a potent natural medicine, able to act against a variety of ailments ranging from high blood pressure and chronic pain to anxiety. In fact, a survey by Gallup found that a large number of Americans who use CBD do so for…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.